The generation of mouse hematopoietic stem cells from hemogenic endothelial cells (HECs) in the aorta/gonad/mesonephros region of developing embryos requires a zinc finger transcription factor Gata2. In the previous study, an enforced expression of Gata2 in vitro promoted the production of HECs from mesodermal cells differentiated from mouse embryonic stem cells (ESCs). Our research group has previously demonstrated that the enforced expression of Gata2 in ESC-derived HECs enhances erythroid and megakaryocyte differentiation and inhibits macrophage differentiation. However, the manner in which the multiple functions of Gata2 are regulated remains unclear. Mouse ESCs differentiate into various types of hematopoietic cells when cocultured with OP9 stromal cells (OP9 system). Using this system and the inducible gene cassette exchange system, which facilitates the establishment of ESCs carrying inducible transgenes under an identical gene expression regulatory unit, the domain-specific functions of Gata2 were systematically dissected in this study. We determined that the N-terminal (amino acid 1-110) region of Gata2 was an erythroidinducing region, both the middle (amino acid 111-200) and C-terminal (amino acid 413-480) regions were megakaryocyte-inducing regions. Furthermore, the present data strongly suggest that intramolecular antagonistic interactions between each of these regions fine-tune the biological functions of Gata2.
| INTRODUCTION
Hematopoietic cells are responsible for growth and homeostasis via the immune surveillance of foreign microorganisms and dysfunctional cells, as critical regulators of hemostasis and as transporters during oxygen/carbon dioxide exchange. Multiple subsets of hematopoietic cells are differentiated from only a small number of hematopoietic stem cells (HSCs) in adults (Ema & Nakauchi, 2003) , and these adult HSCs possess self-renewal activities as well as continuously give rise to more than 10 types of hematopoietic cells throughout their lifespan. Several transcriptional regulatory proteins, termed hematopoietic transcription factors (HTFs), regulate the selfrenewal, lineage specification and differentiation of HSCs.
The activities of HTFs are modulated by protein-protein interactions and post-translational modifications. The interactions of HTFs with other HTFs, cofactors and epigenetic modifiers determine target gene specifications and their transcriptional regulatory activities. These post-translational modifications, which include phosphorylation, acetylation, sumoylation, ubiquitination and methylation, are involved in transcriptional regulatory activities and stabilities as well as physical interactions with other proteins. Thus, the outer regions of the DNA-binding domain are important for the appropriate functions of HTFs.
Gata1-3, which are members of the Gata family, encode well-known HTFs (Orkin, 1992) . Gata1-6 have been identified in mammals; Gata1-3 are predominantly expressed in hematopoietic cells, while Gata4-6 are expressed in nonhematopoietic tissues such as the heart and endoderm-derived tissues (Aronson, Stapleton, & Krasinski, 2014) . All members of the Gata family encode highly conserved two zinc finger domains, which are known as N-finger (NF) and Cfinger (CF) , that recognize the same DNA sequence ([A/T] GATA[A/G]) through their CFs. As these Gata factors play diverging roles during mammalian development, the outer regions of the zinc finger domains are responsible for memberspecific functions. Within the hematopoietic compartment, Gata1 is expressed in erythroid cells, megakaryocytes and mast cells (Morceau, Schnekenburger, Dicato, & Diederich, 2004) , whereas Gata3 is expressed in T-cell lineages (Wan, 2014) . On the other hand, Gata2 is mainly expressed in hematopoietic stem/progenitor cells (HSPCs), megakaryocytes and mast cells in the hematopoietic compartment and is required for the self-renewal of adult HSCs (Rodrigues et al., 2005; Vicente, Conchillo, Garía-Sánchez, & Odero, 2012) . In addition to its pivotal role in adult HSCs, Gata2 is also involved in the generation of HSPCs during mouse embryonic hematopoiesis (Ling et al., 2004; Minegishi et al., 1999 Minegishi et al., , 2003 Robert-Moreno, Espinosa, de la Pompa, & Bigas, 2005) . However, the role that Gata2 plays during embryonic hematopoiesis is not fully understood because Gata2-deficient embryos result in embryonic lethality due to pan-hematopoietic defects (Tsai et al., 1994) .
During mouse embryonic hematopoiesis, the first hematopoietic cells appear in extra-embryonic tissue (i.e., the yolk sac) at 7.5 days postcoitum (dpc) and act as precursors for primitive erythrocytes (Baron, 2003) . Thereafter, hematopoietic progenitor cells (HPCs) with limited potential for self-renewal and differentiation emerge at approximately 8.5-9.5 dpc in the yolk sac and the embryo proper, including the para-aortic splanchnopleura (P-Sp). At last, fully potent HSCs are generated at 10.5 dpc in the P-Sp-derivatives known as the aorta/gonad/mesonephros (AGM) regions. In the yolk sac and the embryo proper, hematopoietic cells develop from hemogenic endothelial cells (HECs) via endothelial-tohematopoietic transitions. HECs are bipotent precursors for hematopoietic and endothelial cells.
In vivo mouse extra-embryonic hematopoiesis can be reiterated by in vitro hematopoietic differentiation induction of mouse embryonic stem cells (ESCs), and, thus, this experimental approach has been used to investigate the functions of Gata2. An in vitro differentiation study of Gata2-deficient mouse ESCs revealed that Gata2 is essential for the proliferation and survival of HPCs (Tsai & Orkin, 1997) . Furthermore, the enforced expression of Gata2 promotes HEC development from ESC-derived mesodermal cells (Lugus et al., 2007) . Our research group also investigated the effects of enforced Gata2 expression on hematopoietic development from mouse ESCs by employing the OP9 stromal cell-based in vitro ESC differentiation method (OP9 system; Nakano, Kodama, & Honjo, 1994 , 1996 Kitajima, Masuhara, Era, Enver, & Nakano, 2002; Kitajima et al., 2006) . Mouse ESCs differentiate into hemogenic mesodermal cells when cocultured with OP9 cells for 5 days (Kitajima, Tanaka, Zheng, Sakai-Ogawa, & Nakano, 2003) and immature hematopoietic cells and primitive erythrocytes emerge on Day 7. The endogenous expression of Gata2 is first detectable on Day 3 and is up-regulated by Day 8 in the absence of exogenous cytokines (Kitajima, Minehata, Sakimura, Nakano, & Hara, 2011) .
When ESCs are cocultured with OP9 cells for 5 days and re-seeded onto fresh OP9 cells in the presence of erythropoietin (EPO), thrombopoietin (TPO) or macrophage colonystimulating factor (M-CSF), erythrocytes, megakaryocytes and macrophages, respectively, are differentiated (Kitajima et al., 2002) . Our research group previously revealed that TPO-induced megakaryocyte production and EPO-induced erythrocyte production are enhanced when exogenous Gata2 is expressed from Day 5 (Kitajima et al., 2002) . In addition, our group showed that M-CSF-induced macrophage differentiation is abolished and that an increased number of megakaryocytes is induced by Gata2 (Kitajima et al., 2002 . In an important way, Gata2 inhibits the transcription of Pu.1 (Sfpi1) via histone deacetylation of its promoter . Pu.1 is a member of the Ets family of transcription factors and is the master regulator of myeloid development. Trichostatin A (TSA), which is a histone deacetylase inhibitor (HDACi), abolishes the Gata2-induced down-regulation of Pu.1 and consequently impairs megakaryocyte differentiation . In addition, the over-expression of Pu.1 suppresses the Gata2-induced differentiation of megakaryocytes. Taken together, these findings suggest that the epigenetic down-regulation of Pu.1 is an underlying molecular mechanism of megakaryocyte induction via Gata2 .
In the recent past, our research group established ESCs harboring an inducible Gata2 gene cassette using the inducible gene cassette exchange (ICE) system (Kawaguchi et al., 2016) . With this system, a single copy of a transgene can be introduced under the doxycycline (dox)-regulatory gene expression unit located on the premodified hypoxanthine guanine phosphoribosyl transferase (Hprt) locus in the ESC genome (Iacovino et al., 2011) . As a result, clonal variations in the established cell lines that are frequently caused by random integrations of the transgene into the host genome are negligible. In addition, as the doxresponsible transactivator rtTA has been introduced into the Rosa26 locus in the ESCs, transgene expression can be controlled in a wide range of cell types that differentiate from ESCs. Using this conditional gene expression system, our research group demonstrated that megakaryocytes induced from ESCs by Gata2 produce functional platelets (Kawaguchi et al., 2016) .
However, because Gata2 plays a role in multiple biological functions during hematopoietic differentiation from ESCs, it remains unclear which domains of Gata2 are specifically responsible for its diverse biological functions. To address this issue in this study, the Gata2 domains were systematically dissected using a combination of the OP9 and ICE systems (OP9/ICE system). Using this methodology, several regions responsible for the specific biological functions of Gata2 were successfully identified. Therefore, this combined methodology can be useful for domain analyses of HTFs.
| RESULTS

| Hematopoietic differentiation of mouse ESCs
We previously demonstrated that Gata2 promotes erythro/ megakaryocyte differentiation from mouse ESC-derived hemogenic mesodermal cells (Kitajima et al., 2002) . To determine the domain-specific functions of Gata2, we assessed whether erythro/megakaryocyte-inducing activity was specific to Gata2 or not, by analyzing the hematopoietic Gata factors, Gata1 and Gata3, and the nonhematopoietic Gata factor, Gata4. Mouse ESCs carrying inducible Gata1 or Gata4 expression were established using the ICE system; mouse ESC lines carrying inducible Gata2 or Gata3 expression have been previously established (Kawaguchi et al., 2016; Kitajima, Kawaguchi, Iacovino, Kyba, & Hara, 2013) . The expression of Gata factors in these ESCs was tightly regulated by dox (Figure 1a) .
When ESCs were cocultured with OP9 stromal cells (Figure 1b by M-CSF, TPO and EPO, respectively, were collected on Day 9, and quantitative RT-PCR analyses were carried out. We also examined the expression levels of exogenous Gata1-4 in undifferentiated ESCs, and these levels were compared with their endogenous expression levels in the hematopoietic cells. The expression of Gata3 and Gata4 was hardly detected in all examined hematopoietic cells (Figure 1e ). The expression of Gata1 and Gata2 was detected in TPO-induced CD41 + megakaryocytes and EPO-induced CD71 hi erythroid cells but not in M-CSF-induced Mac-1 + macrophages (Figure 1e ). When compared with the megakaryocytes and erythroid cells, the expression levels of exogenous Gata1 and Gata2 were approximately two-and fivefolds, respectively ( Figure 1e ).
| Effects of Gata factors on myeloid differentiation
The ESCs carrying inducible Gata factors were induced to differentiate in the absence of the expression of exogenous Gata factors for 5 days on OP9 cells. On Day 5, the HECs were isolated and re-seeded on OP9 cells in the presence of M-CSF and cultured without (Off) or with (On) dox. In the absence of exogenous Gata factor expression (Off), Mac-1 
| Identification of the megakaryocyteinducing region of Gata2
Because Gata4 lacked the ability to induce megakaryocytes ( Figure 2a ,b), the megakaryocyte-inducing region(s) of Gata2 were initially investigated by inserting various regions of Gata2 into the corresponding regions on Gata4. First, the N-terminal (NT) region of Gata2, amino acid (aa) 1-289, was inserted into the corresponding region (aa 1-210) of Gata4 ( Figure 3a) . The resultant chimera, termed G2NT, was introduced into ESCs using the ICE system, and its effects on megakaryocyte induction in the presence of M-CSF were analyzed using the OP9 system. Like as un-tagged Gata4 (Figure 2a ,b), FLAG-tagged Gata4 significantly induced CD71 hi erythroid cells ( Figure 3b ). Compared with Gata4 (FLAG), G2NT conferred megakaryocyte-inducing activity ( Figure 3b ). Next, the NT region was divided into two pieces, termed N1 and N2, and inserted into Gata4 (FLAG) (Figure 3a ). The resultant chimera carrying N1, termed G2N1, could not efficiently induce megakaryocytes, whereas | Genes to Cells
the chimera carrying N2, termed G2N2, strongly induced megakaryocytes (Figure 3b ). On the contrary, the erythroid induction was decreased by G2N2 but was unaffected by G2N1 ( Figure 3b) . Thus, the N2 region (aa 111-289) regulated megakaryocyte-inducing activity. It also appears that the N1 region (aa 1-110) inhibited megakaryocyte induction
F I G U R E 1 Hematopoietic induction of mouse ESCs. (a) The expression of exogenous Gata factors in ESCs carrying inducible Gata1
(iG1), Gata2 (iG2), Gata3 (iG3) and Gata4 (iG4). These ESCs were cultured in ESM without (Off) or with (On) doxycycline ( ESCs (E14) and ESCs with inducible Gata factors (iG1-iG4) were also examined. The expression levels of Gata factors were normalized by ActB, and relative expression levels were shown. Averages were shown as bars and error bars indicated SDs (n = 3), *p < 0.05, **p < 0.005, ***p < 0.0005, compared to the exogenous Gata factor expression because G2N2 produced megakaryocytes more selectively relative to G2NT (Figure 3b ). The expression levels of these chimeric proteins and Gata4 (FLAG) were comparable ( Figure 3c ).
| Failure of Gata2/Gata4 chimerainduced megakaryocytes to fully differentiate
As G2N2 could induce CD41 + Mac-1 − megakaryocytes (Figure 3b ), we analyzed whether the megakaryocytes induced by G2N2 could fully differentiate or not. HECs from ESCs carrying inducible Gata2 or G2N2 ( Figure 4a) were cultured in the presence of TPO on OP9 cells. Without exogenous transgene expression (Cont), most of CD41 + cells
were positive for a late megakaryocyte marker, CD42d, on Day 9 (Figure 4b ). In the CD41 + cells, the exogenous Gata2 expression did not inhibit the expression of CD42d, while G2N2 partially impaired the expression of CD42d ( Figure 4b ). As CD41 + cells differentiated from Gata1-deficient ESCs (G1KO) in TPO on Day 9 failed to express CD42d (Figure 4c ), CD42d would be a transcriptional target of Gata1. These data suggested that G2N2 might affect the function of Gata1.
We next examined whether the N1 region of Gata2 would cancel the inhibitory effect of G2N2 on the CD42d expression in TPO-induced CD41 + cells or not, using G2NT chimera ( Figure 5a ). The expression of CD42d in TPOinduced CD41 + cells on Day 9 was also impaired by G2NT
( Figure 5b ). Further, when the TPO-induced cells were collected on Day 10 and cultured without OP9 cells in TPO for additional 2 days (Day 12), numerous proplatelet-like structures were formed in the absence of transgene expression (Off; Figure 5c ); these proplatelet formations were unaffected by Gata2 but were severely impaired by G2NT (On; Figure 5c ). Next, the cell culture supernatants were collected on Day 12 to score the number of CD41 + CD61 + platelets. The number of platelets was significantly reduced by G2NT (Figure 5d ). The amino acid sequences that differed between Gata2 and G2NT included the two zinc fingers and the C-terminal (CT) region (Figure 5a ). Because the zinc finger regions are highly conserved between Gata2 and Gata4 (Figure 5e ), the absence of Gata2 CT region or the presence of Gata4 CT region would be inhibitory for the CD42d expression and platelet production. Genes to Cells KITAJIMA eT Al.
| Role of the N2 region (aa 111-289) of
Gata2
To clarify whether the N2 region (aa 111-289) was essential for the megakaryocyte-inducing activity of Gata2, Gata2 deletion mutants were constructed and analyzed. The N2 region was divided into two pieces, termed N2a (aa 111-200) and N2b (aa 201-289), and each of these regions was deleted from Gata2 ( Figure 6a ). The Gata2 deletion mutant lacking N2a, termed ∆N2a, failed to induce megakaryocytes, whereas the mutant lacking N2b, termed ∆N2b, retained megakaryocyte-inducing activity (Figure 6b , Supporting Information Figure S1 ). Thus, the N2a region was critical for megakaryocyte induction. The transactivation ability of these mutants was next examined by reporter assays (Figure 7a ). When compared with Gata2, the transactivation ability of ∆N2a was enhanced (Figure 7b) , suggesting that the N2a region contained a negative regulatory domain (NRD). On the other hand, the transactivation ability of ∆N2b was modestly decreased (Figure 7b ).
The N2a region includes a docking site for the serine/ threonine kinase Erk1/2, which is termed the DEF box (Figure 7c ; Katsumura, Ong, DeVilbiss, Sanalkumar, & Bresnick, 2016) . The Gata2 deletion mutant lacking aa 165-186, which includes the DEF box, was termed ∆DEF and resulted in minimal induction of megakaryocytes (Figure 6b , Supporting Information Figure S1 ). Thus, the DEF box was critical for the megakaryocyte-inducing activity of Gata2.
To further dissect the influence of N2a region on megakaryocyte induction, additional Gata2 deletion mutants were analyzed (Figure 6a ). The deletion mutant lacking the N1 region (aa 1-110), termed ∆N1, produced more megakaryocytes than Gata2 (Figure 6b , Supporting Information Figure S1 ); thus, we concluded that the N1 region was inhibitory for the megakaryocyte induction. It has been shown that the N-terminal region of Gata2 is a transactivation domain (TAD; Minegishi, Suzuki, Kawatani, Shimizu, & Yamamoto, 2005) . Consistent with this, the reporter assays revealed that the transactivation ability of ∆N1 was decreased when compared with that of Gata2 (Figure 7b ). In a surprising manner, the ∆N1-2a mutant that lacked the N1 and N2a (aa 1-200) regions exclusively induced megakaryocytes (Figure 6b , Supporting Information Figure S1 ); thus, in the absence of N1 region, the N2a region was dispensable for megakaryocyte induction. Based on these data, it is possible to speculate that the N2a region was required for the megakaryocyte induction via its suppressive effect on the activity of N1 region.
| Role of the CT region (aa 413-489) of Gata2
Because the ∆N1-2a mutant induced megakaryocytes (Figure 6b , Supporting Information Figure S1 ), it could be expected that additional megakaryocyte-inducing region(s) exist Figure S1 ), megakaryocyteinducing region(s) were present in the NF, CF, and CT regions. When CF was deleted from ∆NT, termed ∆NT∆CF (Figure 6a ), this mutant could not effectively inhibit the macrophage differentiation (Figure 6b , Supporting Information Figure S1 ). Thus, DNA-binding activity of Gata2 was essential for the macrophage inhibition. In the same way, when NF was deleted from ∆NT, termed ∆NT∆NF (Figure 6a ), the macrophage inhibitory action was also significantly reduced ( Figure 6b , Supporting Information Figure S1 ). On the other hand, when NF was removed from the ∆N1-2a mutant, termed ∆N1-2a∆NF (Figure 6a ), this mutant could inhibit the macrophage differentiation (Figure 6b , Supporting Information Figure S1 ). These data suggested that the lack of NF might affect the DNA-binding ability of CF when the N2b region was absent. Although ∆N1-2a∆NF mutant inhibited the macrophage differentiation, this mutant unable to induce megakaryocytes as compared with ∆N1-2a mutant (Figure 6b , Supporting Information Figure S1 ). Thus, the NF region was important for the megakaryocyte induction. With curiosity, when CT (aa 413-480) was deleted from ∆NT, termed ∆NT∆CT (Figure 6a ), megakaryocytes were hardly induced (Figure 6b , Supporting Information Figure S1 ). Thus, in addition to the NF and CF regions, the CT region of Gata2 would be necessary for the efficient induction of megakaryocytes. To confirm the requirement of CT region on the megakaryocyte induction, the CT region was removed from Gata2 (∆CT; Figure 6a ). Although the expression level of ∆CT protein was significantly lower than other Gata2 deletion mutants (Figure 6c ), this expression level was sufficient for the inhibition of macrophage differentiation (Figure 6b , Supporting Information Figure S1 ). However, this mutant unable to induce megakaryocytes (Figure 6b , Supporting Information Figure S1 ). The megakaryocyteinducing activities of these mutants were not correlated with their protein expression levels (Figure 6b,c) , suggesting that the differential biological consequences induced by the Gata2 deletion mutants would reflect their functional properties.
| DISCUSSION
| Intramolecular interactions between each of the Gata2 domains
The present study demonstrated that Gata1-4 interfered with macrophage differentiation. Thereby, the Gata factors primarily canceled the macrophage differentiation program.
Next, lineage specification into erythroid cells or megakaryocytes was fine-tuned by their domain-specific functions. Within the amino acid sequences between the N-terminus and NF of Gata2, aa 1-110 (N1) and aa 111-200 (N2a) were responsible for the induction of erythroid cells and megakaryocyte differentiation, respectively. In an important way, aa 1-110 (N1) was the TAD while aa 111-200 (N2a) was the NRD. The fact that aa 111-200 (N2a) was required for the megakaryocyte-inducing activity of Gata2 can be explained by its antagonistic effect on the activity of aa 1-110 (N1) because aa 111-200 (N2a) was not necessary for megakaryocyte induction in the absence of aa 1-110 (N1). On the contrary, the insertion of aa 1-110 (N1) attenuated the megakaryocyte-inducing activities of aa 111-289 (N2), as revealed by the Gata2/Gata4 chimera analyses. Thus, mutually inhibitory intramolecular interactions between aa 1-110 (N1) and aa 111-200 (N2a) would be a determinant in the erythro/megakaryocyte lineage decisions. It is possible that erythroid specification was facilitated when the activity of aa 1-110 (N1) was enhanced. On the contrary, a greater number of megakaryocytes would be induced when aa 111-200 (N2a) efficiently repressed the activity of aa 1-110 (N1).
The Erk1/2 docking site, called the DEF box, is located within aa 111-200 (N2a) of Gata2 and was shown to be important for the megakaryocyte-inducing activity of Gata2. The DEF box is critical for Erk1/2-mediated phosphorylation of multiple Gata2 sites (Katsumura, Yang, Boyer, Li, & Bresnick, 2014; Katsumura et al., 2016) . Within aa 1-110 (N1) of Gata2, Ser 73 is phosphorylated by Erk1/2 (Katsumura et al., 2014) and Gata2 is phosphorylated by IL-3 in an HPC line (Towatari et al., 1995) . Therefore, it can be speculated that extracellular signal(s) might influence Ser 73 phosphorylation via a DEF box-mediated association with Erk1/2 and that Ser 73 phosphorylation would negatively affect the erythroid-inducing activity of aa 1-110 (N1). Thus, the ability of aa 111-200 (N2a) to efficiently repress the activity of aa 1-110 (N1) might be modulated by external stimuli.
| Role of the C-terminal region of Gata2
As ∆CT deletion mutant hardly induced megakaryocytes in M-CSF, aa 413-480 (CT) was important for the megakaryocyte-inducing activity of Gata2. On the other hand, G2NT chimera, carrying Gata4-derived CT region, could induce CD41 + megakaryocytes in the same culture condition. These results suggested that Gata2 CT region could be substituted by Gata4 CT region as far as the induction of CD41 + megakaryocytes. However, the CT region of Gata4 would be inhibitory for TPO-induced full megakaryocyte differentiation, as assessed by CD42d expression and platelet production. Thus, the functional properties of the CT regions in Gata2 and Gata4 differed. Genes to Cells KITAJIMA eT Al. Minegishi et al. (2005) found that the C-terminal region (aa 412-480) of Gata2 possesses transactivation activity, whereas using similar experimental strategies, Morrisey, Ip, Tang, and Parmacek (1997) showed that the C-terminal region (aa 334-440) of Gata4 could not transactivate reporter genes. Thereby, this difference would explain their differential biological functions.
The G2NT chimera impaired CD42d expression in TPO-induced CD41 + cells. This effect would be caused by its interfering action on the function of endogenous Gata1 as CD42d seemed to be a target of Gata1; Gata1-deficient CD41 + cells hardly express CD42d. Gata2 is unable to effectively induce CD42d expression as Gata1-deficient CD41 + cells strongly expressed endogenous Gata2 (Stachura, Chou, & Weiss, 2006) . From these notions, it could be hypothesized that Gata2 and G2NT would bind to CD42d promoter region and weakly transactivate its expression in the absence of Gata1. Afterward, when Gata1 expression is started, Gata2 located on CD42d promoter would be rapidly replaced to Gata1 and CD42d expression might be highly up-regulated. Perhaps, G2NT might continuously occupy the promoter and attenuate Gata1 binding. Taken together, the N-terminal TAD (aa 1-110) of Gata2 was the erythroid-inducing region while the second TAD located in the C-terminal region (aa 413-480) of Gata2 was responsible for the megakaryocyte induction. Further, the activity of the N-terminal TAD of Gata2 was negatively regulated by the adjacent NRD (aa 111-200; Figure 8 ). It would be speculated that the N-terminal TAD might facilitate the transactivation of genes required for erythroid differentiation while the second TAD might be involved in the up-regulation of genes necessary for megakaryocyte differentiation.
Thus, each domain of Gata2 was systematically dissected using the OP9/ICE system and several domains responsible for the specific biological functions of Gata2 were successfully identified. The OP9/ICE system was useful for analyses of the domain-specific function of HTFs.
| EXPERIMENTAL PROCEDURES
| Construction of the shuttle vectors for the ICE system
The ICE system was used to introduce transgenes into the mouse ESCs with the p2lox shuttle vector (Iacovino et al., 2011) . Mouse Gata4 complementary DNA (cDNA) was cloned from endodermal cells differentiated from ESCs by Gata2 expression. Mouse Gata1 and Gata4 cDNAs were subcloned into the p2lox shuttle vector. To construct the Gata2/Gata4 chimeric genes, the DNA sequence encoding the translation initiation codon and the FLAG tag (MDYKDDDDK) were added to the N-termini of Gata2 and Gata4 cDNAs via polymerase chain reaction (PCR) and cloned into pGEM-Teasy cloning vectors using a TA cloning kit (Promega; Madison, WI, USA). Next, various Gata2 and Gata4 fragments were amplified by PCR using primers with overlapping sequences, and the corresponding DNA fragments derived from Gata2 and Gata4 were mixed and amplified by PCR. These constructs were subcloned into the pGEM-Teasy vector.
The Gata2 deletion mutants were constructed via PCR using forward primers that contained additional ATG sequences for ∆N1, ∆N1-2a, ∆NT and ∆NT∆NF and reverse primers that contained DNA sequences encoding their C-termini, Myc tag (EQKLISEEDL) and the stop codon. The mutants were cloned into the pGEM-Teasy vector. To construct the Gata2 internal deletion mutants, all portions of the DNA fragments of Gata2 were amplified by PCR using primers with overlapping sequences and the corresponding DNA fragments were mixed and amplified by PCR. The amplified DNA was cloned into the pGEM-Teasy vector. These constructs were then subcloned into the pGEM-Teasy vector. All DNA sequences were confirmed by DNA sequence analyses, and the constructs were subcloned into the p2lox shuttle vector.
| Culture of mouse ESCs
Mouse A2lox-Cre ESCs, E14tg2a ESCs and Gata1-deficient ESCs 2-mercaptoethanol (2-ME, Sigma), 10 3 units/mL ESGro ® (Invitrogen), 3 μM GSK3β inhibitor (CHIR99021, R&D Systems; Minneapolis, MN, USA) and 1 μM ERK1/2 inhibitor (PD0325901, WAKO; Tokyo, Japan; 2i/LIFM).
| Establishment of mouse ESCs with inducible transgenes
A mouse ESC line, A2lox-Cre, was used for the ICE system (Iacovino et al., 2011) , and transfection of the p2lox shuttle vectors was performed using Lipofectamine 2000 reagents (Gibco-Invitrogen). In brief, A2lox-Cre ESCs (2 × 10 5 ) were seeded onto a gelatin-coated 60-mm dish in 2i/LIFM and precultured in the presence of 1 μg/ml dox (Sigma) for 1 day. Then, the medium was changed to dox-free 2i/LIFM and 2 μg of vector was added to 50 μl of OTPI-MEM (GibcoInvitrogen), while 3 μl of Lipofectamine 2000 was added to 50 μl of OPTI-MEM. After 5 min, the plasmid solution was added to the Lipofectamine 2000-containing mixture, which was incubated at room temperature for 15 min and added to the ESCs; the medium was changed the following day. Two days after transfection, 300 μg/ml of G418 was added; a medium change was performed every day. Then, 3 or 4 days after G418 selection, the cells were washed twice with PBS(-) to remove dead cells and on 7-10 days after G418 selection, and the G418-resistant cells were collected using the Accumax reagent (Innovative Cell Technologies; San Diego, CA, USA) and employed to induce differentiation or for frozen stocks. Because cells in which the transgene was integrated into only the Hprt locus became G418-resistant, colony selection was not needed.
| ESC differentiation using the
OP9 system
OP9 stromal cells were cultured in α-MEM (GibcoInvitrogen) supplemented with 20% FBS (Nichirei Bioscience; Tokyo, Japan), NEAA, 2 mM L-glutamine (Gibco-Invitrogen) and Pen/Str (OP9M). The ESCs were precultured in DMEM supplemented with 15% FBS, Pen/ Str, NEAA, sodium pyruvate, 2-ME and ESGro ® (ESM) 2 days prior to the induction of differentiation (Day -2). On Day 0, the ESCs (3 × 10 4 ) were placed onto OP9 cells in 60-mm dishes in OP9M; half of the medium was replaced 2 days later (Day 2). On Day 5, whole cells, including ESC-derived and OP9 cells, were harvested with an Accumax treatment and Tie-2 + c-Kit + HECs were isolated using FACSAriaIII (BD Biosciences; San Jose, CA, USA). The sorted cells were washed twice with phosphate-buffered saline (PBS) (−)/5% FBS, once with OP9M, and seeded onto OP9 cells. Under normal condition, 2.5 × 10 4 HECs were seeded onto OP9 cells (one well of a 12-well plate) in the presence or absence of cytokines (Supporting Information Table S1 ).
| Flow cytometry
On Day 5 of the induction of ESC differentiation via coculture with OP9 cells, adherent cells were collected using an Accumax reagent. Next, the cells were stained with antibodies in PBS(-)/5% FBS and analyzed with FACSAriaIII. Hematopoietic cells differentiated on OP9 cells were collected by mild pipetting, and the cells were stained with antibodies in PBS(−)/5% FBS and analyzed with LSR Fortessa (BD Biosciences). Platelets were collected as previously described (Kawaguchi et al., 2016) . In brief, prostaglandin E1 (1 mM, Calbiochem; San Diego, CA, USA) was added to the ESCs/ OP9 coculture, and the next day, 10 mM of EDTA was added to the cell culture. Next, the cell culture supernatants were centrifuged (150 g, 10 min, room temperature) to remove mononuclear cells and the supernatants were centrifuged (900 g, 10 min, room temperature) to collect the platelets. Then, the platelets were resuspended in Tyrode-Hepes buffer (5 mM glucose, 1 mM MgCl 2 , 12 mM NaHCO 3 , 2.9 mM KCl, 0.36 mM NaH 2 PO 4 , 138 mM NaCl, 1 mM CaCl 2 and 10 mM Hepes-HCl, pH 7.4), stained with antibodies and analyzed with LSR Fortessa. All antibodies used in the present study are listed in Supporting Information Table S2 .
| Gene expression analyses
Total RNA was purified with the RNeasy mini Kit (Qiagen; Valencia, CA, USA) based on manufacturer recommendations, and cDNA synthesis was carried out using the Primescript RT system (Takara; Shiga, Japan). The reverse transcription (RT)-PCR analyses were performed using rTaq DNA polymerase (Takara); all primers used in this study are listed in Supporting Information Table S3 . The quantitative RT-PCR analyses were carried out on Light Cycler 480 (Roche Diagnostics, Indianapolis, IN) according to the manufacturer's instruction.
Western blot analyses were carried out as previously described. In brief, undifferentiated ESCs with inducible transgenes were cultured in ESM with 1 μg/ml dox for 1 day. Then, 1 × 10 6 cells were collected, suspended in 100 μl of SDS-lysis buffer (20% glycerol, 2% SDS, 5% 2-ME, and 50 mM Tris-Cl, pH6.8) and sonicated. Twenty microliters of the lysate was loaded onto 10%-20% polyacrylamide gel and transferred onto PVDF membrane. The membranes were stained with HRP-conjugated anti-FLAG antibody, HRPconjugated anti-Myc-tag antibody or HRP-conjugated antiActB antibody (all from Abcam, Cambridge, MA).
| Analyses of transactivation activities
ESCs carrying inducible transgenes were precultured in ESM for 1 day (Day -1), and a reporter vector, pGata1-luc
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or pScl-luc (Kitajima et al., 2002) , was transfected together with pRL-TK vector with Lipofectamine 2000 (Day 0). On Day 1, the ESCs were subcultured with or without dox, and, on Day 2, the cells were harvested and cell lysates were prepared. The luciferase activities of the cell lysates were analyzed with a dual luciferase reporter assay system (Promega), and the luciferase activities were normalized based on the activity of pRL-TK.
